Bristol-Myers to buy Celgene in a $74 billion deal; Celgene shares surge
January 03, 2019 at 07:03 AM EST
Bristol-Myers on Thursday announced plans to buy Celgene in a deal the company valued at $74 billion.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|